PLIN1 anticorps (C-Term)
Aperçu rapide pour PLIN1 anticorps (C-Term) (ABIN4956509)
Antigène
Voir toutes PLIN1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 507-519, C-Term
-
Réactivité croisée
- Boeuf (Vache), Humain
-
Immunogène
- C-terminus of perilipin (aa 507-519)
-
-
-
-
Indications d'application
- Dilution for IHC: 1:100 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- serum
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
-
- PLIN1 (Perilipin 1 (PLIN1))
-
Autre désignation
- perilipin/ PLN1
-
Sujet
- Perilipins build a family of phosphoproteins. The predominant forms in adipocytes, perilipin / PLIN1 A and B arise by alternative RNA splicing from a single gene, generating polypeptides of 57 and 46 kD, respectively. The antiserum reacts specifically with perilipin / PLIN1 located at the surface of intracellular storage lipid droplets present e.g. in the adrenal gland, adipocytes of white and brown adipose tissue and cultured cells such as adipocytes and cultured steroidogenic adrenal cortical and Leydig cells. The antiserum does not cross-react with adipophilin (ADRP, also named PLIN2) or TIP47 (also named PLIN3) proteins, or additional members of the PLIN/PAT-family , e.g. MLDP or OXPAT/PAT-1, also named PLIN5, LSDP5.
-
Pathways
- Lipid Metabolism
Antigène
-